FIELD: medicine.
SUBSTANCE: method involves concurrently determining acid alpha-1 glycoprotein concentration in blood serum at exacerbation stage and in 2 weeks after treatment beginning. Acid alpha-1 glycoprotein concentration falling from 2.1-2.5 to 1.6-1.8 g/l, the pemphigus clinical course is considered to be heavy. The value falling from 1.9-2 to 1.4-1.55 g/l, the pemphigus clinical course is considered to be favorable.
EFFECT: improved reliability of diagnosis; accelerating stable remission achievement.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ESTIMATING INFLAMMATORY PROCESS ACTIVITY IN PEMPHIGUS CASES | 2006 |
|
RU2316003C1 |
| METHOD FOR ESTIMATING PEMPHIGUS TREATMENT EFFECTIVENESS | 2006 |
|
RU2316005C1 |
| METHOD FOR EVALUATING INFLAMMATORY PROCESS ACTIVITY AT PSORIASIS | 2005 |
|
RU2290645C1 |
| METHOD FOR ESTIMATING PSORIATIC ERYTHRODERMIA TREATMENT EFFECTIVENESS | 2005 |
|
RU2297004C1 |
| METHOD FOR PREDICTING THE CHANCE FOR OSTEOMYELITIS CHRONIZATION IN CHILDREN | 2006 |
|
RU2304784C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF AUTOIMMUNE PEMPHIGUS | 2010 |
|
RU2429482C1 |
| METHOD OF ASSESSING INFLAMMATORY PROCESS ACTIVITY IN SARCOIDOSIS | 2010 |
|
RU2423701C1 |
| METHOD OF PROBABILITY PREDICTION OF CHILDREN CHRONIC HAEMATOGENOUS OSTEOMYELITIS DEVELOPMENT | 2007 |
|
RU2341798C1 |
| METHOD FOR PREDICTING COURSE OF ISOLATED FORM OF ACANTHOLYTIC PERVASIVE CAVITY | 2018 |
|
RU2688209C1 |
| METHOD FOR DETERMINING BLOOD STATE OF AGGREGATION IN INFANTINE INFLAMMATORY PROCESS CASES | 2006 |
|
RU2319965C1 |
